Influence of passive permeability on apparent P-glycoprotein kinetics

Area of Science:

• Pharmacokinetics and Drug Transport
• Cellular Permeability Studies
• P-glycoprotein (P-gp) Interactions

Background:

• P-glycoprotein (P-gp) is an efflux transporter that significantly impacts drug absorption and distribution.
• Understanding P-gp kinetics is crucial for predicting drug efficacy and avoiding adverse drug reactions.
• Passive permeability is a key factor influencing drug interaction with P-gp.

Purpose of the Study:

• To evaluate the role of moderate passive permeability in apparent P-glycoprotein (P-gp) kinetics.
• To demonstrate how permeability ratios can lead to overlooking P-gp substrates and inhibitors.
• To investigate P-gp substrate and inhibitor properties of nicardipine, vinblastine, cimetidine, and ranitidine.

Main Methods:

• Determined permeability ratios of nicardipine, vinblastine, cimetidine, and ranitidine across Caco-2 and hMDRI-MDCK monolayers.
• Assessed the effect of a specific P-gp inhibitor (GF120918) on permeability ratios.
• Investigated the impact of drug pretreatment on vinblastine's permeability ratio.

Main Results:

• Permeability ratios >2 for cimetidine and vinblastine, indicating P-gp substrate identification based on ratios alone.
• Permeability ratios near unity for nicardipine and ranitidine, unaffected by GF120918.
• Nicardipine and ranitidine, despite unity ratios, acted as P-gp substrates and inhibitors, affecting vinblastine transport.

Conclusions:

• Moderate passive permeability is essential for P-gp to reduce drug permeability.
• Directional permeability studies alone are insufficient to identify all P-gp substrates and inhibitors.
• Drug interaction studies are more effective than directional permeability studies for a comprehensive understanding of P-gp kinetics.